11 Mar 2009 07:00
RNS Number : 6468O
Akers Biosciences, Inc.
11 March 2009
11 March 2009
Akers Biosciences, Inc.
Notice of Preliminary Results
Akers Biosciences, Inc. (AIM:AKR), a leading designer and manufacturer of rapid diagnostic screening and testing products, announces that it will publish results for the year ended 31 December 2008 on Tuesday, 24 March 2009.
For further information please contact:
Thomas A. Nicolette
President and CEO
Tel. +1 856 848 8698
Ben Simons
M: Communications
Tel. +44 (0)20 7153 1540
Alasdair Younie
Arbuthnot Securities Limited
Tel. +44 (0)20 7012 2000
This information is provided by RNS
The company news service from the London Stock Exchange
AKR.L (AKR)